uniQure

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell uniQure and other ETFs, options, and stocks.

About QURE

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems.

CEO

Matthew C. Kapusta

CEOMatthew C. Kapusta

Employees

209

Employees209

Headquarters

Amsterdam, Noord-Holland

HeadquartersAmsterdam, Noord-Holland

Founded

2012

Founded2012

Employees

209

Employees209

QURE Key Statistics

Market cap

751.15M

Market cap751.15M

Price-Earnings ratio

-3.12

Price-Earnings ratio-3.12

Dividend yield

—

Dividend yield—

Average volume

2.95M

Average volume2.95M

High today

$14.16

High today$14.16

Low today

$13.20

Low today$13.20

Open price

$13.61

Open price$13.61

Volume

1.62M

Volume1.62M

52 Week high

$19.18

52 Week high$19.18

52 Week low

$3.73

52 Week low$3.73

Analyst ratings

86%

of 14 ratings

Buy

85.7%

Hold

14.3%

Sell

People also own

Based on the portfolios of people who own QURE. This list is generated using Robinhood data, and it’s not a recommendation.